The dermatology CRO market refers to the industry of contract research organizations (CROs) that provide specialized services to support the development and commercialization of dermatological products, such as drugs, devices, and cosmetics. These services include preclinical and clinical trial management, regulatory affairs, data management, and bioanalysis. Dermatology CROs work with pharmaceutical, biotechnology and medical device companies, as well as academic institutions and researchers, to help them bring new dermatological products to market. The global dermatology CRO market is expected to reach $3.3 billion by 2023, growing at a CAGR of 11.2% during the forecast period (2018-2023).
Over the course of the projection period, market growth is anticipated to be aided by increased investment in R&D programs, a desire to outsource tasks due to time and cost constraints, and the expiration of patents in the dermatological sector. Because dermatological CROs offer cutting-edge services that enable the sector to expand, pharmaceutical corporations and governmental organizations like entrusting them with projects.
Download Free Sample Copy of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=7178
Market Segments Covered in Dermatology CRO Industry Analysis
- By Type:
- Drug Discovery
- Target Validation
- Lead Identification
- Lead Optimization
- Phase I
- Phase II
- Phase III
- Phase IV
- Drug Discovery
- By Service:
- Project Management/Clinical Supply Management
- Data Management
- Regulatory/Medical Affairs
- Medical Writing
- Clinical Monitoring
- Quality Management/Assurance
- Investigator Payments
- Patient and Site Recruitment
- Other Services
- By Region:
- North America
- Latin America
Get Customization on this Report for Specific Research Solutions – https://www.factmr.com/connectus/sample?flag=RC&rep_id=7178
Key Companies Profiled
- IQVIA HOLDINGS INC.
- Covance Inc.
- Pharmaceutical Product Development, LLC (PPD)
- Parexel International Corporation
- Charles River Laboratories International, Inc.
- Icon, Plc
- Medidata Solutions, Inc.
- Syneos Health
- GVK Biosciences Private Limited
- Wuxi AppTec
- MEDPACE HOLDINGS, INC.
- PRA Health Sciences
- CTI Clinical Trial & Consulting
Key Takeaways from the Market Study
- Global Dermatology CRO market is expected to reach a market size of US$ 4.3 Bn by 2022
- Clinical dermatology CRO is expected to be the highest revenue generating category, accounting for an absolute dollar opportunity of nearly US$ 3.5 Bn during 2022 – 2032.
- Top service being Clinical Monitoring is expected to grow at a CAGR of over 7% during 2022 – 2032.
- With nearly 10% projected growth rate, Dermatology CRO revenue is expected to grow at fastest pace in U.S in North America, during 2022 – 2032.
- The Dermatology CRO market reached a valuation of US$ 4.3 Bn in 2022 as the worldwide revenues was up by 8.6% year-over-year.
For in-depth competitive analysis, Buy Now – https://www.factmr.com/checkout/7178
More Insights Available
Fact.MR, in its new offering, presents an unbiased analysis of the Dermatology CRO market, presenting historical market data (2015-2021) and forecast statistics for the period of 2022-2032.
The study reveals essential insights on the basis of Type (Drug Discovery, Clinical, Preclinical), by Service (Project Management, Data Management, Medical Affairs, Medical Writing, Clinical Monitoring, Quality Management, Bio-statistics, Investigator Payments, Laboratory, Patient and Site Recruitment, Technology, Other Services) across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).
US Sales Office:
11140 Rockville Pike
Rockville, MD 20852
Tel: +1 (628) 251-1583